just target

Fostering Rare Cancer Drug Development

The TargetCancer Foundation Industry Roundtable is a bi-annual invitation-only meeting that unites partners in the rare cancer and tissue-agnostic drug development spaces. This highly interactive, discussion-based meeting allows companies to discuss common challenges and opportunities for collaboration. In addition, key research, clinical, regulatory, and other stakeholders from the TargetCancer Foundation community attend and provide their perspectives. The initiatives generated through these action-oriented meetings are developed and led by TargetCancer Foundation.

Two Medical Professionals, Researchers
2023 Industry Roundtable logo

2023 Industry Roundtable

Our inaugural Industry Roundtable took place in November 2023, inspiring a vibrant, ongoing conversation about rare cancer and tissue-agnostic drug development.

20231116 AL8I5442 scaled
roundtable scaled

Thank You to Our 2023 Industry Roundtable Sponsors:

AADI Bioscience
Blueprint Medicines
Boehringer Ingelheim
Jazz Pharmaceuticals
Taiho Oncology